Trial Profile
A phase II study of navelbine (vinorelbine) in elderly patients with advanced/metastatic breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 02 Aug 2005
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 02 Aug 2005 New trial record.